Table 2 |
|||||
|
Association of MYCN/c-MYC target gene clusters with overall survival in primary neuroblastomas (n = 251) |
|||||
|
Cluster |
Number of genes |
Rank OS* |
p-value OS† |
Rank OS with CV* |
p-value OS with CV† |
|
|
|||||
|
168 (I) |
19 |
3 |
<0.0001 |
1 |
0.0004 |
|
140 (I) |
38 |
4 |
<0.0001 |
2 |
0.0006 |
|
195 (I) |
21 |
31 |
<0.0001 |
12 |
0.0060 |
|
308 (II) |
33 |
18 |
<0.0001 |
26 |
0.0161 |
|
280 (II) |
32 |
29 |
<0.0001 |
37 |
0.0232 |
|
336 (II) |
26 |
51 |
<0.0001 |
45 |
0.0280 |
|
|
|||||
|
*Rank of all 504 clusters tested for association with overall survival (OS) using the Global test without and with adjustment for co-variables (CV; amplified MYCN, stages 1, 2, 3, 4s versus 4, age at diagnosis ≥1.5 years). †p-value from Global test adjusted for multiple testing. In the Cluster column, I or II gives the cluster group as defined by the SOM analysis using SH-EPMYCN cells. |
|||||
|
Westermann et al. Genome Biology 2008 9:R150 doi:10.1186/gb-2008-9-10-r150 |
|||||